APO Research

APO RESEARCH · REPORT

Vonoprazan Fumarate Tablets

Selected research

Industry Growth & Trends

Global Vonoprazan Fumarate Tablets Industry Growth and Trends Forecast to 2032

Market perspective

The global Vonoprazan Fumarate Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Vonoprazan Fumarate Tablets include Sichuan Kelun Pharmaceutical, Sichuan Haihui Pharmaceutical, Shandong New Era Pharmaceutical and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Vonoprazan Fumarate Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Vonoprazan Fumarate Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Vonoprazan Fumarate Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Vonoprazan Fumarate Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Vonoprazan Fumarate Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Vonoprazan Fumarate Tablets Market by Company

Sichuan Kelun Pharmaceutical

Sichuan Haihui Pharmaceutical

Shandong New Era Pharmaceutical

Takeda Pharmaceutical

Vonoprazan Fumarate Tablets Segment by Type

10mg

20mg

Vonoprazan Fumarate Tablets Segment by Application

Hospital Pharmacy

Retail Pharmacy

Vonoprazan Fumarate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vonoprazan Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vonoprazan Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vonoprazan Fumarate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Vonoprazan Fumarate Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Vonoprazan Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 20mg Table 3. Global Vonoprazan Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 5. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Vonoprazan Fumarate Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Vonoprazan Fumarate Tablets Sales by Type (2027-2032) & (K Units) Table 10. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Vonoprazan Fumarate Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Vonoprazan Fumarate Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 15. North America Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 17. Europe Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 21. Latin America Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Vonoprazan Fumarate Tablets Industry Trends Table 25. Vonoprazan Fumarate Tablets Industry Drivers Table 26. Vonoprazan Fumarate Tablets Industry Opportunities and Challenges Table 27. Vonoprazan Fumarate Tablets Industry Restraints Table 28. Global Vonoprazan Fumarate Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Vonoprazan Fumarate Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Vonoprazan Fumarate Tablets Sales by Company (2021-2026) & (K Units) Table 31. Global Vonoprazan Fumarate Tablets Sales Share by Company (2021-2026) Table 32. Global Vonoprazan Fumarate Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Vonoprazan Fumarate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Vonoprazan Fumarate Tablets Major Company Production Sites and Headquarters Table 35. Global Vonoprazan Fumarate Tablets Company, Product Type & Application Table 36. Global Vonoprazan Fumarate Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Vonoprazan Fumarate Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Vonoprazan Fumarate Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Vonoprazan Fumarate Tablets Sales by Region (2021-2026) & (K Units) Table 41. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Vonoprazan Fumarate Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Vonoprazan Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Vonoprazan Fumarate Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Vonoprazan Fumarate Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Vonoprazan Fumarate Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Vonoprazan Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 52. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Vonoprazan Fumarate Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Vonoprazan Fumarate Tablets Sales by Application (2027-2032) & (K Units) Table 57. Global Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Vonoprazan Fumarate Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Vonoprazan Fumarate Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Vonoprazan Fumarate Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 62. North America Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 64. Europe Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 68. Latin America Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Sichuan Kelun Pharmaceutical Company Information Table 72. Sichuan Kelun Pharmaceutical Business Overview Table 73. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio Table 75. Sichuan Kelun Pharmaceutical Recent Development Table 76. Sichuan Haihui Pharmaceutical Company Information Table 77. Sichuan Haihui Pharmaceutical Business Overview Table 78. Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio Table 80. Sichuan Haihui Pharmaceutical Recent Development Table 81. Shandong New Era Pharmaceutical Company Information Table 82. Shandong New Era Pharmaceutical Business Overview Table 83. Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio Table 85. Shandong New Era Pharmaceutical Recent Development Table 86. Takeda Pharmaceutical Company Information Table 87. Takeda Pharmaceutical Business Overview Table 88. Takeda Pharmaceutical Vonoprazan Fumarate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Takeda Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio Table 90. Takeda Pharmaceutical Recent Development Table 91. North America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Vonoprazan Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 93. North America Vonoprazan Fumarate Tablets Sales Market Share by Country (2021-2026) Table 94. North America Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Vonoprazan Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 96. North America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Vonoprazan Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Vonoprazan Fumarate Tablets Market Share by Country (2021-2026) Table 99. North America Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Vonoprazan Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 101. Europe Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Vonoprazan Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 103. Europe Vonoprazan Fumarate Tablets Sales Market Share by Country (2021-2026) Table 104. Europe Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Vonoprazan Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Vonoprazan Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Vonoprazan Fumarate Tablets Market Share by Country (2021-2026) Table 109. Europe Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Vonoprazan Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Vonoprazan Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Vonoprazan Fumarate Tablets Market Share by Country (2021-2026) Table 119. Asia-Pacific Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Vonoprazan Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 121. Latin America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Vonoprazan Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 123. Latin America Vonoprazan Fumarate Tablets Sales Market Share by Country (2021-2026) Table 124. Latin America Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Vonoprazan Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Vonoprazan Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Vonoprazan Fumarate Tablets Market Share by Country (2021-2026) Table 129. Latin America Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Vonoprazan Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Vonoprazan Fumarate Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Vonoprazan Fumarate Tablets Market Share by Country (2021-2026) Table 139. Middle East and Africa Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Vonoprazan Fumarate Tablets Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Vonoprazan Fumarate Tablets Distributors List Table 144. Vonoprazan Fumarate Tablets Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Vonoprazan Fumarate Tablets Image Figure 2. Global Vonoprazan Fumarate Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vonoprazan Fumarate Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Vonoprazan Fumarate Tablets Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 20mg Image Figure 8. Global 20mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Vonoprazan Fumarate Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Vonoprazan Fumarate Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Vonoprazan Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Vonoprazan Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Vonoprazan Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Vonoprazan Fumarate Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Vonoprazan Fumarate Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Vonoprazan Fumarate Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Vonoprazan Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Vonoprazan Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Vonoprazan Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Vonoprazan Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Vonoprazan Fumarate Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Vonoprazan Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Vonoprazan Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Vonoprazan Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Vonoprazan Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Vonoprazan Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Vonoprazan Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Vonoprazan Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Vonoprazan Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Vonoprazan Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Vonoprazan Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Vonoprazan Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Vonoprazan Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Vonoprazan Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Vonoprazan Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Vonoprazan Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Vonoprazan Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Vonoprazan Fumarate Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Vonoprazan Fumarate Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Vonoprazan Fumarate Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Vonoprazan Fumarate Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Vonoprazan Fumarate Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Vonoprazan Fumarate Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 20mg
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Sichuan Kelun Pharmaceutical
  • Sichuan Haihui Pharmaceutical
  • Shandong New Era Pharmaceutical
  • Takeda Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vonoprazan Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Vonoprazan Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Vonoprazan Fumarate Tablets Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 20mg
  8. 1.4 Global Vonoprazan Fumarate Tablets Market Size by Type
  9. 1.4.1 Global Vonoprazan Fumarate Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Vonoprazan Fumarate Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Vonoprazan Fumarate Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Vonoprazan Fumarate Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Vonoprazan Fumarate Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Vonoprazan Fumarate Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Vonoprazan Fumarate Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Vonoprazan Fumarate Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Vonoprazan Fumarate Tablets Industry Trends
  2. 2.2 Vonoprazan Fumarate Tablets Industry Drivers
  3. 2.3 Vonoprazan Fumarate Tablets Industry Opportunities and Challenges
  4. 2.4 Vonoprazan Fumarate Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Vonoprazan Fumarate Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Vonoprazan Fumarate Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Vonoprazan Fumarate Tablets Price (2021-2026)
  4. 3.4 Global Vonoprazan Fumarate Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Vonoprazan Fumarate Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Vonoprazan Fumarate Tablets Company, Product Type & Application
  7. 3.7 Global Vonoprazan Fumarate Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Vonoprazan Fumarate Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Vonoprazan Fumarate Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Vonoprazan Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Vonoprazan Fumarate Tablets Regional Status and Outlook
  1. 4.1 Global Vonoprazan Fumarate Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Vonoprazan Fumarate Tablets Historic Market Size by Region
  3. 4.2.1 Global Vonoprazan Fumarate Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Vonoprazan Fumarate Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Vonoprazan Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Vonoprazan Fumarate Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Vonoprazan Fumarate Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Vonoprazan Fumarate Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Vonoprazan Fumarate Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Vonoprazan Fumarate Tablets by Application
  1. 5.1 Vonoprazan Fumarate Tablets Market by Application
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Vonoprazan Fumarate Tablets Market Size by Application
  5. 5.2.1 Global Vonoprazan Fumarate Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Vonoprazan Fumarate Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Vonoprazan Fumarate Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Vonoprazan Fumarate Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Vonoprazan Fumarate Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Vonoprazan Fumarate Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Vonoprazan Fumarate Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Vonoprazan Fumarate Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sichuan Kelun Pharmaceutical
  2. 6.1.1 Sichuan Kelun Pharmaceutical Company Information
  3. 6.1.2 Sichuan Kelun Pharmaceutical Business Overview
  4. 6.1.3 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
  6. 6.1.5 Sichuan Kelun Pharmaceutical Recent Developments
  7. 6.2 Sichuan Haihui Pharmaceutical
  8. 6.2.1 Sichuan Haihui Pharmaceutical Company Information
  9. 6.2.2 Sichuan Haihui Pharmaceutical Business Overview
  10. 6.2.3 Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
  12. 6.2.5 Sichuan Haihui Pharmaceutical Recent Developments
  13. 6.3 Shandong New Era Pharmaceutical
  14. 6.3.1 Shandong New Era Pharmaceutical Company Information
  15. 6.3.2 Shandong New Era Pharmaceutical Business Overview
  16. 6.3.3 Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
  18. 6.3.5 Shandong New Era Pharmaceutical Recent Developments
  19. 6.4 Takeda Pharmaceutical
  20. 6.4.1 Takeda Pharmaceutical Company Information
  21. 6.4.2 Takeda Pharmaceutical Business Overview
  22. 6.4.3 Takeda Pharmaceutical Vonoprazan Fumarate Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Takeda Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
  24. 6.4.5 Takeda Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Vonoprazan Fumarate Tablets Sales by Country
  2. 7.1.1 North America Vonoprazan Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Vonoprazan Fumarate Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Vonoprazan Fumarate Tablets Market Size by Country
  6. 7.2.1 North America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Vonoprazan Fumarate Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Vonoprazan Fumarate Tablets Sales by Country
  2. 8.1.1 Europe Vonoprazan Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Vonoprazan Fumarate Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Vonoprazan Fumarate Tablets Market Size by Country
  6. 8.2.1 Europe Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Vonoprazan Fumarate Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Vonoprazan Fumarate Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Vonoprazan Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Vonoprazan Fumarate Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Vonoprazan Fumarate Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Vonoprazan Fumarate Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Vonoprazan Fumarate Tablets Sales by Country
  2. 10.1.1 South America Vonoprazan Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Vonoprazan Fumarate Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Vonoprazan Fumarate Tablets Market Size by Country
  6. 10.2.1 South America Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Vonoprazan Fumarate Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Vonoprazan Fumarate Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Vonoprazan Fumarate Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Vonoprazan Fumarate Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Vonoprazan Fumarate Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Vonoprazan Fumarate Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Vonoprazan Fumarate Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Vonoprazan Fumarate Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Vonoprazan Fumarate Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Vonoprazan Fumarate Tablets Value Chain Analysis
  2. 12.1.1 Vonoprazan Fumarate Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Vonoprazan Fumarate Tablets Production Mode & Process
  7. 12.2 Vonoprazan Fumarate Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Vonoprazan Fumarate Tablets Distributors
  10. 12.2.3 Vonoprazan Fumarate Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research